VIH/sida - VIH au temps du Covid-19 : rencontre de deux pandémies [HIV in the time of COVID-19 : the meeting between two pandemics]
Fiche du document
13 janvier 2021
- doi: 10.53738/REVMED.2021.17.720-21.0095
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.720-21.0095
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33443839
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_BA14B82E08534
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
TherapyCiter ce document
O. Nawej Tshikung et al., « VIH/sida - VIH au temps du Covid-19 : rencontre de deux pandémies [HIV in the time of COVID-19 : the meeting between two pandemics] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.720-21.0095
Métriques
Partage / Export
Résumé
The current COVID-19 pandemic is the main topic of news worldwide by its magnitude and consequences across the entire planet. From a medical point of view, several risk factors for developing severe illness have been reported in the literature, notably an immunosuppressed status. For people living with HIV, several questions have been raised concerning not only their vulnerability, but also in relation to an eventual protection conferred by antiretroviral therapy. This article will address these two pandemics by looking at the potential impact of SARS-CoV-2 on people living with HIV and, in parallel, exploring similarities and differences in terms of treatment, potential for recovery, prevention and their impact on clinical research. We review also future novel therapies for the treatment of HIV.